Apoptosis inducer for cancer cell

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8809296
APP PUB NO 20130090370A1
SERIAL NO

13629226

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention revealed that by suppressing the expression of the WRN gene, the BLM gene, or the RecQ1 gene, which belong to the RecQ helicase family, apoptosis is induced in various cancer cells and their proliferation is suppressed. Compounds that suppress the expression of RecQ helicase family genes or the functions of RecQ helicase proteins are thought to have the activity of inducing apoptosis.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
GENECARE RESEARCH INSTITUTE CO LTDKAMAKURA-SHI KANAGAWA 247-0063

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Furuichi, Yasuhiro Kamakura, JP 26 89
Sato, Ayumi Kamakura, JP 43 337
Shimamoto, Akira Kamakura, JP 19 132
Takagi, Motoki Kamakura, JP 13 74

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Feb 19, 2026
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00